GENERATION BIO CO. news, videos and press releases
For more news please use our advanced search feature.
GENERATION BIO CO. - More news...
GENERATION BIO CO. - More news...
- Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
- Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
- Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
- Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
- Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results
- Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
- Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
- Generation Bio Reports Second Quarter 2024 Financial Results
- Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
- Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
- Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
- Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
- Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
- Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Generation Bio to Present at the 2024 TD Cowen Health Care Conference
- Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
- Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
- Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
- Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
- Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
- Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
- Generation Bio Reports Second Quarter 2023 Financial Results
- Generation Bio to Present at the 2023 Jefferies Healthcare Conference
- Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
- Generation Bio to Present at the JMP Securities Life Sciences Conference
- Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
- Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
- Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
